Clinical Trial Update: Multicenter Study to Assess the Efficacy and Safety of LB-102 in the Treatment of Adult Patients With BP1MDE. [Phase 2]

View source ↗

Summary

A Phase 2 multicenter clinical trial evaluating LB-102 for Bipolar I Disorder is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• LB-102 (LB-102)

Snippet

Sponsor: LB Pharmaceuticals Inc. | Conditions: Bipolar I Disorder | Phase 2 | Status: RECRUITING